Hypertrophic scar (HS) is a pathological outcome of wound healing, characterized by excessive fibroblast activation and abnormal extracellular matrix deposition. Recent studies indicate that metabolic changes, particularly in lipid pathways, are involved in fibroblast regulation and scar progression. Current treatments often show limited efficacy and high recurrence. To better understand the underlying mechanisms, we analyzed transcriptomic datasets of HS and normal fibroblasts. We identified 64 lipid metabolism-related genes that were differentially expressed, with enrichment in the linoleic acid and sphingolipid metabolic pathways. LASSO regression highlighted lipase A (LIPA) as a key hub gene. Receiver operating characteristic analysis confirmed the high diagnostic accuracy of LIPA. Experimental validation in TGF-β1-stimulated fibroblasts demonstrated consistent upregulation of expression at both mRNA and protein levels. Functional assays showed that silencing LIPA significantly inhibited fibroblast proliferation and migration. Furthermore, molecular docking with five commonly used HS drugs-5-fluorouracil, betamethasone, imiquimod, triamcinolone, and verapamil-identified betamethasone as the strongest binding compound for LIPA, suggesting potential pharmacological targeting. Collectively, these findings establish LIPA as a lipid metabolism-related biomarker and therapeutic target in HS. This study provides a mechanistic framework linking lipid metabolism to scar progression and supports strategies targeting metabolic pathways for precise HS therapy.
Background & aims: Thyroid cancer is prone to early lymph node metastasis.This study investigated the influence of iron status on thyroid cancer risk and its mediating role in the relationship between thyroid cancer incidence and thyroid cancer-related exposure factors. Method: Utilizing iron status-related Single Nucleotide Polymorphisms as instrumental variables, the research analyzed summary data on iron status and thyroid cancer from Genome-Wide Association Studies following the Two-sample Mendelian randomization guidelines, primarily using the Inverse-variance weighted method, with Mendelian randomization-Egger method, weighted median method, simple mode, and weighted mode as supplementary analyses. The reliability and robustness of the results were assessed using the Leave-one-out analysis and Cochran’s Q Test. Results: The findings indicate that the iron status has a vital causal relationship with the occurrence of thyroid cancer. The Inverse-variance weighted model results revealed Iron || id:ieu-a-1049: OR = 1.409, 95%CI = (1.043, 1.904), P < 0.05; Ferritin || id:ieu-a-1050: OR = 2.029, 95% CI = (1.081, 3.808), P < 0.05; Transferrin Saturation || id:ieu-a-1051: OR = 1.337, 95%CI = (1.058, 1.690), P < 0.05. The reliability and robustness of these results were further supported by the Leave-one-out analysis and Cochran’s Q Test (P > 0.05). Conclusion: The study establishes a certain causal link between iron status and thyroid cancer, indicating that transferrin saturation, serum ferritin and serum iron are associated with thyroid cancer incidence.
Background: Thyroid-related eye disease (TED) is the most prevalent orbital disorder of autoimmune origin, yet research on its mitochondrial energy metabolism-related genes remains limited with no definitive biomarkers or therapeutic targets identified.Methods: We downloaded datasets from the GEO database, forming TED and Control groups. Mitochondrial energy metabolism-related genes (MEMRGs) were sourced from GeneCards. We conducted differential gene expression analysis, gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment, gene set enrichment analysis (GSEA), and identified Key Genes. A diagnostic logistic regression model was then built, expression differences validated, immune infiltration analyzed via ssGSEA, and network interaction assessed. Results: After correcting batch effects in datasets GSE58331 and GSE105149, we identified 26 mitochondrial energy metabolism-related differentially expressed genes (MEMRDEGs). Through one-way logistic analysis, Random Forest, and a LASSO risk model, we pinpointed 10 Key Genes crucial for diagnosis. The diagnostic model demonstrated superior performance and accuracy, with Key Genes showing significantly higher expression in the TED group. Additionally, activated CD8 T cells, immature B cells, and T follicular helper cells exhibited notable differences. Conclusions: The expression of mitochondrial energy metabolism-related genes in TED, stratified by risk score levels, exhibits a positive correlation with immune activity, unveiling a promising new pathway for identifying therapeutic targets. This finding calls for deeper biological exploration.